BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21428745)

  • 1. Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes.
    Kennedy DJ; Kashyap SR
    Metab Syndr Relat Disord; 2011 Aug; 9(4):239-45. PubMed ID: 21428745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD36- a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?
    Koonen DP; Jensen MK; Handberg A
    Arch Physiol Biochem; 2011 May; 117(2):57-63. PubMed ID: 21250778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
    Wisse BE
    J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role and function of macrophages in the metabolic syndrome.
    Bhargava P; Lee CH
    Biochem J; 2012 Mar; 442(2):253-62. PubMed ID: 22329799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
    Martínez-Clemente M; Clària J; Titos E
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance.
    Handberg A; Levin K; Højlund K; Beck-Nielsen H
    Circulation; 2006 Sep; 114(11):1169-76. PubMed ID: 16952981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD36 and macrophages in atherosclerosis.
    Collot-Teixeira S; Martin J; McDermott-Roe C; Poston R; McGregor JL
    Cardiovasc Res; 2007 Aug; 75(3):468-77. PubMed ID: 17442283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in obesity as the underlying cause for the metabolic syndrome.
    Gallagher EJ; Leroith D; Karnieli E
    Mt Sinai J Med; 2010; 77(5):511-23. PubMed ID: 20960553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and the metabolic syndrome.
    Vega GL
    Minerva Endocrinol; 2004 Jun; 29(2):47-54. PubMed ID: 15257255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review.
    Reddy KJ; Singh M; Bangit JR; Batsell RR
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):633-47. PubMed ID: 20164784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionizing radiation induces macrophage foam cell formation and aggregation through JNK-dependent activation of CD36 scavenger receptors.
    Katayama I; Hotokezaka Y; Matsuyama T; Sumi T; Nakamura T
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):835-46. PubMed ID: 18262097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. n-3 PUFA: bioavailability and modulation of adipose tissue function.
    Kopecky J; Rossmeisl M; Flachs P; Kuda O; Brauner P; Jilkova Z; Stankova B; Tvrzicka E; Bryhn M
    Proc Nutr Soc; 2009 Nov; 68(4):361-9. PubMed ID: 19698199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors, inflammation, metabolism and obesity.
    Fresno M; Alvarez R; Cuesta N
    Arch Physiol Biochem; 2011 Jul; 117(3):151-64. PubMed ID: 21599616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory signaling in skeletal muscle insulin resistance: green signal for nutritional intervention?
    Hommelberg PP; Langen RC; Schols AM; Mensink RP; Plat J
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):647-55. PubMed ID: 20842028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose tissue macrophages.
    Zeyda M; Stulnig TM
    Immunol Lett; 2007 Oct; 112(2):61-7. PubMed ID: 17719095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A personalized approach to metabolic aspects of obesity.
    Brietzke SA
    Mt Sinai J Med; 2010; 77(5):499-510. PubMed ID: 20960552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.